Announcements

25 October 2023
Current Oncology | Top Cited Papers in 2021 in the Section “Bone and Soft Tissue Oncology”

As Current Oncology (ISSN: 1718-7729) is of an open access format, you have free and unlimited access to the full text of all articles published in our journal. We welcome you to read our 2021 top cited papers in the Section “Bone and Soft Tissue Oncology” listed below:

1. “Synovial Sarcoma: A Clinical Review”
by Aaron M. Gazendam, Snezana Popovic, Sohaib Munir, Naveen Parasu, David Wilson and Michelle Ghert
Curr. Oncol. 2021, 28(3), 1909–1920; https://doi.org/10.3390/curroncol28030177
Available online: https://www.mdpi.com/1718-7729/28/3/177

2. “Current Overview of Treatment for Metastatic Bone Disease”
by Shinji Tsukamoto, Akira Kido, Yasuhito Tanaka, Giancarlo Facchini, Giuliano Peta, Giuseppe Rossi and Andreas F. Mavrogenis
Curr. Oncol. 2021, 28(5), 3347–3372; https://doi.org/10.3390/curroncol28050290
Available online: https://www.mdpi.com/1718-7729/28/5/290

3. “Emerging Concepts in the Surgical Management of Peri-Acetabular Metastatic Bone Disease”
by Aaron Gazendam, Daniel Axelrod, David Wilson and Michelle Ghert
Curr. Oncol. 2021, 28(4), 2731–2740; https://doi.org/10.3390/curroncol28040238
Available online: https://www.mdpi.com/1718-7729/28/4/238

4. “The Role of a Navigational Radiofrequency Ablation Device and Concurrent Vertebral Augmentation for Treatment of Difficult-to-Reach Spinal Metastases”
by Claudio Pusceddu, Davide De Francesco, Luca Melis, Nicola Ballicu and Alessandro Fancellu
Curr. Oncol. 2021, 28(5), 4004–4015; https://doi.org/10.3390/curroncol28050340
Available online: https://www.mdpi.com/1718-7729/28/5/340

5. “The Surgical Management of Proximal Femoral Metastases: A Narrative Review”
by Daniel Axelrod, Aaron M. Gazendam and Michelle Ghert
Curr. Oncol. 2021, 28(5), 3748–3757; https://doi.org/10.3390/curroncol28050320
Available online: https://www.mdpi.com/1718-7729/28/5/320

6. “We’re on a Merry-Go-Round”: Reflections of Patients and Carers after Completing Treatment for Sarcoma”
by Rhys Weaver, Moira O’Connor, Richard Carey Smith, Dianne Sheppard and Georgia K. B. Halkett
Curr. Oncol. 2021, 28(4), 3003–3014; https://doi.org/10.3390/curroncol28040263
Available online: https://www.mdpi.com/1718-7729/28/4/263

7. “Assessment of Risk of Bias in Osteosarcoma and Ewing’s Sarcoma Randomized Controlled Trials: A Systematic Review”
by Robert Koucheki, Aaron M. Gazendam, Jonathan R. Perera, Anthony Griffin, Peter Ferguson, Jay Wunder and Kim Tsoi
Curr. Oncol. 2021, 28(5), 3771–3794; https://doi.org/10.3390/curroncol28050322
Available online: https://www.mdpi.com/1718-7729/28/5/322

8. “Impact of an Augmented Reality Navigation System (SIRIO) on Bone Percutaneous Procedures: A Comparative Analysis with Standard CT-Guided Technique”
by Eliodoro Faiella, Gennaro Castiello, Caterina Bernetti, Giuseppina Pacella, Carlo Altomare, Flavio Andresciani, Bruno Beomonte Zobel and Rosario Francesco Grasso
Curr. Oncol. 2021, 28(3), 1751–1760; https://doi.org/10.3390/curroncol28030163
Available online: https://www.mdpi.com/1718-7729/28/3/163

9. “Clinical Benefit from Lenvatinib and Pembrolizumab Observed in Mullerian Adenosarcoma: A Case Report”
by Thierry Alcindor, Sungmi Jung and Lucy Gilbert
Curr. Oncol. 2021, 28(3), 2146–2149; https://doi.org/10.3390/curroncol28030199
Available online: https://www.mdpi.com/1718-7729/28/3/199

10. “The Role of Denosumab for Surgical Outcomes in Patients with Giant Cell Tumour of Bone: A Systematic Review”
by Abha Gupta, Lisa Durocher-Allen, Snezana Popovic, Richard Tozer, Xiaomei Yao and Michelle Ghert
Curr. Oncol. 2021, 28(2), 1302–1313; https://doi.org/10.3390/curroncol28020124
Available online: https://www.mdpi.com/1718-7729/28/2/124

More News...
Back to TopTop